HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Massimo Caputo Chris A. Rogers Qiang Chen Gianni D. Angelini Andrew J. Parry Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Caputo, M. Articles by Parry, A. J. Search for Related Content PubMed Articles by Caputo, M. Articles by Parry, A. J. Related Collections Congenital - cyanotic Myocardial protection

J Thorac Cardiovasc Surg 2009;138:206-214
© 2009 The American Association for Thoracic Surgery

Perioperative Management

The effects of normoxic versus hyperoxic cardiopulmonary bypass on oxidative stress and inflammatory response in cyanotic pediatric patients undergoing open cardiac surgery: A randomized controlled trial

^a Bristol Heart Institute, Bristol, United Kingdom
^b Bristol Royal Hospital for Children, Bristol, United Kingdom

Received for publication September 19, 2008; revisions received November 21, 2008; accepted for publication December 25, 2008.

^_* Address for reprints: M. Caputo, MD, Bristol Heart Institute, University of Bristol, Bristol Royal Children's Hospital, Bristol, BS2 8HW, United Kingdom. (Email: M.Caputo{at}bris.ac.uk).

Objectives: This study investigates the effects of controlled reoxygenation cardiopulmonary bypass on oxidative stress, inflammatory response, and organ function in children undergoing repair of cyanotic congenital heart defects.

Methods: Sixty-seven cyanotic patients (median age 15 months, interquartile range 6–49 months) undergoing corrective cardiac surgery were randomized to receive either controlled normoxic (50–0 mm Hg; n = 35) or hyperoxic (150–180 mm Hg; n = 32) cardiopulmonary bypass. Troponin I and 8-isoprostane, C3a, interleukins 6, 8, and 10, cortisol, protein S100, and alpha-glutamate transferase were measured preoperatively and 10 and 30 minutes after starting bypass, on removal of the aortic crossclamp, and 12 and 24 hours thereafter.

Results: Overall, troponin I and 8-isoprostane levels were lower in the controlled normoxic group (–29%, 95% CI –48% to –3%, P = .03, and –26%, 95% CI –44% to –2%, P = .03, respectively). Protein S100 release was also lower in the normoxic group 10 minutes after starting bypass (–26%, 95% CI –40% to –9%, P = .005) and 10 minutes after aortic crossclamp removal (–23%, 95% CI –38% to –3%, P = .02, respectively), but similar at other time points in the two groups (P .17). The alpha-glutamate transferase release was significantly lower in the normoxic group 10 minutes after aortic crossclamp removal (–28%, 95% CI –44% to –9%, P = .006, respectively) but was similar at other times (P .11). Release of C3a, interleukins 6, 8, and 10, and cortisol was similar in the two groups throughout (P .15).

Conclusion: Controlled reoxygenation on starting cardiopulmonary bypass is associated with reduced myocardial damage, oxidative stress, and cerebral and hepatic injury compared with hyperoxic bypaass and similar whole body inflammatory and stress response in cyanotic children undergoing open cardiac surgery.